HYBRID EVENT: You can participate in person at Madrid, Spain or Virtually from your home or work.

5th Edition of Global Conference on Surgery and Anaesthesia

September 05-07, 2024 | Hybrid Event

September 05 -07, 2024 | Madrid, Spain
GCSA 2024

Noninvasive respiratory management of ventilatory pump failure: how and why no one needs a tracheostomy tube for only being too weak to breathe

John R Bach, Speaker at Anaesthesia Conferences
Rutgers University, United States
Title : Noninvasive respiratory management of ventilatory pump failure: how and why no one needs a tracheostomy tube for only being too weak to breathe


Home mechanical ventilation became possible once electricity became widely available. From 1930 through 1952, noninvasive ventilatory support (NVS) was via negative pressure body ventilators, subsequently it became possible via tracheostomy (TVS) or up to continuous noninvasive ventilatory support (CNVS). 

Candidates for definitive noninvasive management of ventilatory pump failure (VPF) have very involved families and absence of severe upper motor neuron disease. Interventions for definitive up to CNVS include NVS via oral, nasal, and oronasal interfaces, and intermittent abdominal pressure ventilator. These permit extubation and trach tube decannulations of ventilator unweanable (vital capacity as low as 0 ml) patients who satisfy specific criteria. An oximetry, NVS, mechanical in-exsufflation (MIE) protocol is used to avoid intubations and for successful extubation and decannulation. NVS settings are about 20 cm H2O pressure support (PS) by bi-level or pressure assist ventilation, by volume targeted bi-level, or preferably by volume preset ventilation over a range of 650 to 1500 ml. This range permits optimal rest, support, lung expansion, and tidal volume variation.

In 1993 257 VPF patients were published who left Iron Lungs in 1954 in favor of up to CNVS via mouthpiece,??? None were known to have died from respiratory causes. Several continue to use mouthpiece CNVS today, now for 70 years. The same center has 20 patients with spinal muscular atrophy type 1 (SMA1), nasal CNVS dependent from as young as 3 months of age, with only trace residual ocular movements, now between 20 and 30 years of age, all with 0 ml of VC. Over 270 consecutive intubated, ventilator unweanable VPF patients, including with SMA1, satisfying specific criteria were extubated, and over 100 decannulated of trach tubes, despite having no ventilator free breathing ability.

Considering that tracheotomy tubes increase ventilator dependence and hinder weaning, cause morbidity and mortality, enormous expense for nursing care, and are not desired by patients who can use NVS and MIE in the community, it because evident that no one needs a trach tube for only being too weak to breathe.


Dr. John R. Bach is a Professor of Physical Medicine and Rehabilitation and a Professor of Neurology at Rutgers University in New Jersey, USA. He has over 300 peer-reviewed publications and 13 books translated into 4 languages and has lectured on noninvasive management of ventilatory pump failure in over 40 countries. He has directed the Howard Rusk Ventilator Unit and Kessler Institute Ventilator Units and received many awards including the Newark Beth Israel Health Care Foundation Humanism in Medicine Award.